Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: The HCM-LGE risk score | Synapse
January 10, 2026
Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: The HCM-LGE risk score
Key Points
The aim is to develop a risk score based on late gadolinium enhancement for predicting mortality in hypertrophic cardiomyopathy patients.
Developed a scoring system utilizing magnetic resonance imaging findings
Analyzed late gadolinium enhancement patterns
Assessed clinical outcomes over follow-up periods
Higher LGE scores correlate with increased mortality risk
Patients with extensive LGE showed significantly worse outcomes
The risk score effectively stratified patients based on mortality risk